乳房切除术后放疗情况下的全国乳房重建利用率
National Breast Reconstruction Utilization in the Setting of Postmastectomy Radiotherapy.
作者信息
Razdan Shantanu N, Cordeiro Peter G, Albornoz Claudia R, Disa Joseph J, Panchal Hina J, Ho Alice Y, Momoh Adeyiza O, Matros Evan
机构信息
Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
出版信息
J Reconstr Microsurg. 2017 Jun;33(5):312-317. doi: 10.1055/s-0037-1598201. Epub 2017 Feb 24.
Immediate breast reconstruction (IBR) is often deferred, when postmastectomy radiotherapy (PMRT) is anticipated, due to high complication rates. Nonetheless, because of robust data supporting improved health-related quality of life associated with reconstruction, physicians and patients may be more accepting of tradeoffs. The current study explores national trends of IBR utilization rates and methods in the setting of PMRT, using the National Cancer Database (NCDB). The study hypothesis is that prosthetic techniques have become the most common method of IBR in the setting of PMRT. NCDB was queried from 2004 to 2013 for women, who underwent mastectomy with or without IBR. Patients were grouped according to PMRT status. Multivariate logistic regression was used to calculate odds of IBR in the setting of PMRT. Trend analyses were done for rates and methods of IBR using Poisson regression to determine incidence rate ratios (IRRs). In multivariate analysis, radiated patients were 30% less likely to receive IBR ( < 0.05). The rate increase in IBR was greater in radiated compared with nonradiated patients (IRR: 1.12 vs. 1.09). Rates of reconstruction increased more so in radiated compared with nonradiated patients for both implants (IRR 1.15 vs. 1.11) and autologous techniques (IRR 1.08 vs. 1.06). Autologous reconstructions were more common in those receiving PMRT until 2005 ( < 0.05), with no predominant technique thereafter. Although IBR remains a relative contraindication, rates of IBR are increasing to a greater extent in patients receiving PMRT. Implants have surpassed autologous techniques as the most commonly used method of breast reconstruction in this setting.
由于并发症发生率较高,当预计要进行乳房切除术后放疗(PMRT)时,即刻乳房重建(IBR)常常会被推迟。尽管如此,由于有强有力的数据支持重建可改善与健康相关的生活质量,医生和患者可能会更愿意接受权衡。本研究利用国家癌症数据库(NCDB)探讨了在PMRT背景下IBR的利用率和方法的全国趋势。研究假设是,在PMRT背景下,假体技术已成为IBR最常用的方法。
从2004年到2013年,对国家癌症数据库进行查询,以获取接受或未接受IBR的乳房切除术女性患者的信息。患者根据PMRT状态进行分组。使用多变量逻辑回归计算在PMRT背景下接受IBR的几率。使用泊松回归对IBR的发生率和方法进行趋势分析,以确定发病率比(IRR)。
在多变量分析中,接受放疗的患者接受IBR的可能性降低30%(P<0.05)。与未接受放疗的患者相比,接受放疗患者的IBR发生率增加幅度更大(IRR:1.12对1.09)。对于植入物(IRR 1.15对1.11)和自体技术(IRR 1.08对1.06),接受放疗患者的重建率增加幅度均大于未接受放疗的患者。直到2005年,自体重建在接受PMRT的患者中更为常见(P<0.05),此后没有哪种技术占主导地位。
尽管IBR仍然是相对禁忌证,但在接受PMRT的患者中,IBR的发生率正在更大程度地增加。在这种情况下,植入物已超过自体技术,成为最常用的乳房重建方法。